Medical Care
Global Biosimilar Testing and Development Services Market Research Report 2025
- Sep 06, 25
- ID: 492563
- Pages: 74
- Figures: 80
- Views: 2
This report aims to provide a comprehensive presentation of the global market for Biosimilar Testing and Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Testing and Development Services.
The Biosimilar Testing and Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosimilar Testing and Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilar Testing and Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Segment by Type
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Segment by Application
PK assay
Tiered Immunogenicity testing
NAb assays
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar Testing and Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Biosimilar Testing and Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosimilar Testing and Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilar Testing and Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Segment by Type
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Segment by Application
PK assay
Tiered Immunogenicity testing
NAb assays
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar Testing and Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Effector Binding
1.2.3 ELISA
1.2.4 Kinetic Binding Assays
1.2.5 ADCC & CDC Cell-Based Assays
1.3 Market by Application
1.3.1 Global Biosimilar Testing and Development Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing and Development Services Market Perspective (2020-2031)
2.2 Global Biosimilar Testing and Development Services Growth Trends by Region
2.2.1 Global Biosimilar Testing and Development Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biosimilar Testing and Development Services Historic Market Size by Region (2020-2025)
2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Region (2026-2031)
2.3 Biosimilar Testing and Development Services Market Dynamics
2.3.1 Biosimilar Testing and Development Services Industry Trends
2.3.2 Biosimilar Testing and Development Services Market Drivers
2.3.3 Biosimilar Testing and Development Services Market Challenges
2.3.4 Biosimilar Testing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing and Development Services Players by Revenue
3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2020-2025)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2020-2025)
3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biosimilar Testing and Development Services Revenue
3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2024
3.5 Global Key Players of Biosimilar Testing and Development Services Head office and Area Served
3.6 Global Key Players of Biosimilar Testing and Development Services, Product and Application
3.7 Global Key Players of Biosimilar Testing and Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing and Development Services Breakdown Data by Type
4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2020-2025)
4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2026-2031)
5 Biosimilar Testing and Development Services Breakdown Data by Application
5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2020-2025)
5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biosimilar Testing and Development Services Market Size (2020-2031)
6.2 North America Biosimilar Testing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biosimilar Testing and Development Services Market Size by Country (2020-2025)
6.4 North America Biosimilar Testing and Development Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size (2020-2031)
7.2 Europe Biosimilar Testing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biosimilar Testing and Development Services Market Size by Country (2020-2025)
7.4 Europe Biosimilar Testing and Development Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size (2020-2031)
8.2 Asia-Pacific Biosimilar Testing and Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimilar Testing and Development Services Market Size (2020-2031)
9.2 Latin America Biosimilar Testing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biosimilar Testing and Development Services Market Size by Country (2020-2025)
9.4 Latin America Biosimilar Testing and Development Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size (2020-2031)
10.2 Middle East & Africa Biosimilar Testing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.1.5 Eurofins Scientific Recent Development
11.2 SGS
11.2.1 SGS Company Details
11.2.2 SGS Business Overview
11.2.3 SGS Biosimilar Testing and Development Services Introduction
11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.2.5 SGS Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.3.5 Charles River Laboratories Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Details
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 Exova
11.5.1 Exova Company Details
11.5.2 Exova Business Overview
11.5.3 Exova Biosimilar Testing and Development Services Introduction
11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.5.5 Exova Recent Development
11.6 Source BioScience
11.6.1 Source BioScience Company Details
11.6.2 Source BioScience Business Overview
11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.6.5 Source BioScience Recent Development
11.7 Intertek Group
11.7.1 Intertek Group Company Details
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.7.5 Intertek Group Recent Development
11.8 Medistri
11.8.1 Medistri Company Details
11.8.2 Medistri Business Overview
11.8.3 Medistri Biosimilar Testing and Development Services Introduction
11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.8.5 Medistri Recent Development
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Details
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.9.5 Pace Analytical Services Recent Development
11.10 Sigma-Aldrich
11.10.1 Sigma-Aldrich Company Details
11.10.2 Sigma-Aldrich Business Overview
11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.10.5 Sigma-Aldrich Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Effector Binding
1.2.3 ELISA
1.2.4 Kinetic Binding Assays
1.2.5 ADCC & CDC Cell-Based Assays
1.3 Market by Application
1.3.1 Global Biosimilar Testing and Development Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing and Development Services Market Perspective (2020-2031)
2.2 Global Biosimilar Testing and Development Services Growth Trends by Region
2.2.1 Global Biosimilar Testing and Development Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biosimilar Testing and Development Services Historic Market Size by Region (2020-2025)
2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Region (2026-2031)
2.3 Biosimilar Testing and Development Services Market Dynamics
2.3.1 Biosimilar Testing and Development Services Industry Trends
2.3.2 Biosimilar Testing and Development Services Market Drivers
2.3.3 Biosimilar Testing and Development Services Market Challenges
2.3.4 Biosimilar Testing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing and Development Services Players by Revenue
3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2020-2025)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2020-2025)
3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biosimilar Testing and Development Services Revenue
3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2024
3.5 Global Key Players of Biosimilar Testing and Development Services Head office and Area Served
3.6 Global Key Players of Biosimilar Testing and Development Services, Product and Application
3.7 Global Key Players of Biosimilar Testing and Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing and Development Services Breakdown Data by Type
4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2020-2025)
4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2026-2031)
5 Biosimilar Testing and Development Services Breakdown Data by Application
5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2020-2025)
5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biosimilar Testing and Development Services Market Size (2020-2031)
6.2 North America Biosimilar Testing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biosimilar Testing and Development Services Market Size by Country (2020-2025)
6.4 North America Biosimilar Testing and Development Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size (2020-2031)
7.2 Europe Biosimilar Testing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biosimilar Testing and Development Services Market Size by Country (2020-2025)
7.4 Europe Biosimilar Testing and Development Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size (2020-2031)
8.2 Asia-Pacific Biosimilar Testing and Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimilar Testing and Development Services Market Size (2020-2031)
9.2 Latin America Biosimilar Testing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biosimilar Testing and Development Services Market Size by Country (2020-2025)
9.4 Latin America Biosimilar Testing and Development Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size (2020-2031)
10.2 Middle East & Africa Biosimilar Testing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.1.5 Eurofins Scientific Recent Development
11.2 SGS
11.2.1 SGS Company Details
11.2.2 SGS Business Overview
11.2.3 SGS Biosimilar Testing and Development Services Introduction
11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.2.5 SGS Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.3.5 Charles River Laboratories Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Details
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 Exova
11.5.1 Exova Company Details
11.5.2 Exova Business Overview
11.5.3 Exova Biosimilar Testing and Development Services Introduction
11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.5.5 Exova Recent Development
11.6 Source BioScience
11.6.1 Source BioScience Company Details
11.6.2 Source BioScience Business Overview
11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.6.5 Source BioScience Recent Development
11.7 Intertek Group
11.7.1 Intertek Group Company Details
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.7.5 Intertek Group Recent Development
11.8 Medistri
11.8.1 Medistri Company Details
11.8.2 Medistri Business Overview
11.8.3 Medistri Biosimilar Testing and Development Services Introduction
11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.8.5 Medistri Recent Development
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Details
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.9.5 Pace Analytical Services Recent Development
11.10 Sigma-Aldrich
11.10.1 Sigma-Aldrich Company Details
11.10.2 Sigma-Aldrich Business Overview
11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2020-2025)
11.10.5 Sigma-Aldrich Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Effector Binding
Table 3. Key Players of ELISA
Table 4. Key Players of Kinetic Binding Assays
Table 5. Key Players of ADCC & CDC Cell-Based Assays
Table 6. Global Biosimilar Testing and Development Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biosimilar Testing and Development Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biosimilar Testing and Development Services Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biosimilar Testing and Development Services Market Share by Region (2020-2025)
Table 10. Global Biosimilar Testing and Development Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biosimilar Testing and Development Services Market Share by Region (2026-2031)
Table 12. Biosimilar Testing and Development Services Market Trends
Table 13. Biosimilar Testing and Development Services Market Drivers
Table 14. Biosimilar Testing and Development Services Market Challenges
Table 15. Biosimilar Testing and Development Services Market Restraints
Table 16. Global Biosimilar Testing and Development Services Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biosimilar Testing and Development Services Market Share by Players (2020-2025)
Table 18. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2024)
Table 19. Ranking of Global Top Biosimilar Testing and Development Services Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biosimilar Testing and Development Services Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biosimilar Testing and Development Services, Headquarters and Area Served
Table 22. Global Key Players of Biosimilar Testing and Development Services, Product and Application
Table 23. Global Key Players of Biosimilar Testing and Development Services, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilar Testing and Development Services Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2020-2025)
Table 27. Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2026-2031)
Table 29. Global Biosimilar Testing and Development Services Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2020-2025)
Table 31. Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2026-2031)
Table 33. North America Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biosimilar Testing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biosimilar Testing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biosimilar Testing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biosimilar Testing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biosimilar Testing and Development Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biosimilar Testing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biosimilar Testing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eurofins Scientific Company Details
Table 49. Eurofins Scientific Business Overview
Table 50. Eurofins Scientific Biosimilar Testing and Development Services Product
Table 51. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 52. Eurofins Scientific Recent Development
Table 53. SGS Company Details
Table 54. SGS Business Overview
Table 55. SGS Biosimilar Testing and Development Services Product
Table 56. SGS Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 57. SGS Recent Development
Table 58. Charles River Laboratories Company Details
Table 59. Charles River Laboratories Business Overview
Table 60. Charles River Laboratories Biosimilar Testing and Development Services Product
Table 61. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 62. Charles River Laboratories Recent Development
Table 63. Pharmaceutical Product Development Company Details
Table 64. Pharmaceutical Product Development Business Overview
Table 65. Pharmaceutical Product Development Biosimilar Testing and Development Services Product
Table 66. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 67. Pharmaceutical Product Development Recent Development
Table 68. Exova Company Details
Table 69. Exova Business Overview
Table 70. Exova Biosimilar Testing and Development Services Product
Table 71. Exova Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 72. Exova Recent Development
Table 73. Source BioScience Company Details
Table 74. Source BioScience Business Overview
Table 75. Source BioScience Biosimilar Testing and Development Services Product
Table 76. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 77. Source BioScience Recent Development
Table 78. Intertek Group Company Details
Table 79. Intertek Group Business Overview
Table 80. Intertek Group Biosimilar Testing and Development Services Product
Table 81. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 82. Intertek Group Recent Development
Table 83. Medistri Company Details
Table 84. Medistri Business Overview
Table 85. Medistri Biosimilar Testing and Development Services Product
Table 86. Medistri Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 87. Medistri Recent Development
Table 88. Pace Analytical Services Company Details
Table 89. Pace Analytical Services Business Overview
Table 90. Pace Analytical Services Biosimilar Testing and Development Services Product
Table 91. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 92. Pace Analytical Services Recent Development
Table 93. Sigma-Aldrich Company Details
Table 94. Sigma-Aldrich Business Overview
Table 95. Sigma-Aldrich Biosimilar Testing and Development Services Product
Table 96. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 97. Sigma-Aldrich Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Biosimilar Testing and Development Services Picture
Figure 2. Global Biosimilar Testing and Development Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biosimilar Testing and Development Services Market Share by Type: 2024 VS 2031
Figure 4. Effector Binding Features
Figure 5. ELISA Features
Figure 6. Kinetic Binding Assays Features
Figure 7. ADCC & CDC Cell-Based Assays Features
Figure 8. Global Biosimilar Testing and Development Services Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biosimilar Testing and Development Services Market Share by Application: 2024 VS 2031
Figure 10. PK assay Case Studies
Figure 11. Tiered Immunogenicity testing Case Studies
Figure 12. NAb assays Case Studies
Figure 13. Biosimilar Testing and Development Services Report Years Considered
Figure 14. Global Biosimilar Testing and Development Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Biosimilar Testing and Development Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Biosimilar Testing and Development Services Market Share by Region: 2024 VS 2031
Figure 17. Global Biosimilar Testing and Development Services Market Share by Players in 2024
Figure 18. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2024
Figure 20. North America Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Biosimilar Testing and Development Services Market Share by Country (2020-2031)
Figure 22. United States Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Biosimilar Testing and Development Services Market Share by Country (2020-2031)
Figure 26. Germany Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Biosimilar Testing and Development Services Market Share by Region (2020-2031)
Figure 34. China Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Biosimilar Testing and Development Services Market Share by Country (2020-2031)
Figure 42. Mexico Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Biosimilar Testing and Development Services Market Share by Country (2020-2031)
Figure 46. Turkey Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 50. SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 51. Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 52. Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 53. Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 54. Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 55. Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 56. Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 57. Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 58. Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Effector Binding
Table 3. Key Players of ELISA
Table 4. Key Players of Kinetic Binding Assays
Table 5. Key Players of ADCC & CDC Cell-Based Assays
Table 6. Global Biosimilar Testing and Development Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biosimilar Testing and Development Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biosimilar Testing and Development Services Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biosimilar Testing and Development Services Market Share by Region (2020-2025)
Table 10. Global Biosimilar Testing and Development Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biosimilar Testing and Development Services Market Share by Region (2026-2031)
Table 12. Biosimilar Testing and Development Services Market Trends
Table 13. Biosimilar Testing and Development Services Market Drivers
Table 14. Biosimilar Testing and Development Services Market Challenges
Table 15. Biosimilar Testing and Development Services Market Restraints
Table 16. Global Biosimilar Testing and Development Services Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biosimilar Testing and Development Services Market Share by Players (2020-2025)
Table 18. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2024)
Table 19. Ranking of Global Top Biosimilar Testing and Development Services Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biosimilar Testing and Development Services Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biosimilar Testing and Development Services, Headquarters and Area Served
Table 22. Global Key Players of Biosimilar Testing and Development Services, Product and Application
Table 23. Global Key Players of Biosimilar Testing and Development Services, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilar Testing and Development Services Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2020-2025)
Table 27. Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2026-2031)
Table 29. Global Biosimilar Testing and Development Services Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2020-2025)
Table 31. Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2026-2031)
Table 33. North America Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biosimilar Testing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biosimilar Testing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biosimilar Testing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biosimilar Testing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biosimilar Testing and Development Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biosimilar Testing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biosimilar Testing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eurofins Scientific Company Details
Table 49. Eurofins Scientific Business Overview
Table 50. Eurofins Scientific Biosimilar Testing and Development Services Product
Table 51. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 52. Eurofins Scientific Recent Development
Table 53. SGS Company Details
Table 54. SGS Business Overview
Table 55. SGS Biosimilar Testing and Development Services Product
Table 56. SGS Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 57. SGS Recent Development
Table 58. Charles River Laboratories Company Details
Table 59. Charles River Laboratories Business Overview
Table 60. Charles River Laboratories Biosimilar Testing and Development Services Product
Table 61. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 62. Charles River Laboratories Recent Development
Table 63. Pharmaceutical Product Development Company Details
Table 64. Pharmaceutical Product Development Business Overview
Table 65. Pharmaceutical Product Development Biosimilar Testing and Development Services Product
Table 66. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 67. Pharmaceutical Product Development Recent Development
Table 68. Exova Company Details
Table 69. Exova Business Overview
Table 70. Exova Biosimilar Testing and Development Services Product
Table 71. Exova Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 72. Exova Recent Development
Table 73. Source BioScience Company Details
Table 74. Source BioScience Business Overview
Table 75. Source BioScience Biosimilar Testing and Development Services Product
Table 76. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 77. Source BioScience Recent Development
Table 78. Intertek Group Company Details
Table 79. Intertek Group Business Overview
Table 80. Intertek Group Biosimilar Testing and Development Services Product
Table 81. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 82. Intertek Group Recent Development
Table 83. Medistri Company Details
Table 84. Medistri Business Overview
Table 85. Medistri Biosimilar Testing and Development Services Product
Table 86. Medistri Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 87. Medistri Recent Development
Table 88. Pace Analytical Services Company Details
Table 89. Pace Analytical Services Business Overview
Table 90. Pace Analytical Services Biosimilar Testing and Development Services Product
Table 91. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 92. Pace Analytical Services Recent Development
Table 93. Sigma-Aldrich Company Details
Table 94. Sigma-Aldrich Business Overview
Table 95. Sigma-Aldrich Biosimilar Testing and Development Services Product
Table 96. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2020-2025) & (US$ Million)
Table 97. Sigma-Aldrich Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Biosimilar Testing and Development Services Picture
Figure 2. Global Biosimilar Testing and Development Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biosimilar Testing and Development Services Market Share by Type: 2024 VS 2031
Figure 4. Effector Binding Features
Figure 5. ELISA Features
Figure 6. Kinetic Binding Assays Features
Figure 7. ADCC & CDC Cell-Based Assays Features
Figure 8. Global Biosimilar Testing and Development Services Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biosimilar Testing and Development Services Market Share by Application: 2024 VS 2031
Figure 10. PK assay Case Studies
Figure 11. Tiered Immunogenicity testing Case Studies
Figure 12. NAb assays Case Studies
Figure 13. Biosimilar Testing and Development Services Report Years Considered
Figure 14. Global Biosimilar Testing and Development Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Biosimilar Testing and Development Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Biosimilar Testing and Development Services Market Share by Region: 2024 VS 2031
Figure 17. Global Biosimilar Testing and Development Services Market Share by Players in 2024
Figure 18. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2024
Figure 20. North America Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Biosimilar Testing and Development Services Market Share by Country (2020-2031)
Figure 22. United States Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Biosimilar Testing and Development Services Market Share by Country (2020-2031)
Figure 26. Germany Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Biosimilar Testing and Development Services Market Share by Region (2020-2031)
Figure 34. China Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Biosimilar Testing and Development Services Market Share by Country (2020-2031)
Figure 42. Mexico Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Biosimilar Testing and Development Services Market Share by Country (2020-2031)
Figure 46. Turkey Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Biosimilar Testing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 50. SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 51. Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 52. Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 53. Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 54. Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 55. Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 56. Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 57. Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 58. Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232